J, B., JH, P., M, L., HJ, J., CM, L., CK, K., . . . MD, O. (2024). Clinicomicrobiological risk factors for infective endocarditis in viridans group streptococci bacteraemia. The Journal of antimicrobial chemotherapy, 79(9), 2327. https://doi.org/10.1093/jac/dkae231
Chicago Style (17th ed.) CitationJ, Bae, et al. "Clinicomicrobiological Risk Factors for Infective Endocarditis in Viridans Group Streptococci Bacteraemia." The Journal of Antimicrobial Chemotherapy 79, no. 9 (2024): 2327. https://doi.org/10.1093/jac/dkae231.
MLA (9th ed.) CitationJ, Bae, et al. "Clinicomicrobiological Risk Factors for Infective Endocarditis in Viridans Group Streptococci Bacteraemia." The Journal of Antimicrobial Chemotherapy, vol. 79, no. 9, 2024, p. 2327, https://doi.org/10.1093/jac/dkae231.